CN Patent

CN112778301A — 四氢吡啶并嘧啶类抑制剂及其制备方法和应用

Assigned to Shanghai Zejing Pharmaceutical Technology Co ltd · Expires 2021-05-11 · 5y expired

What this patent protects

本发明涉及四氢吡啶并嘧啶类抑制剂及其制备方法和应用。具体地，本发明化合物具有式(I)所示结构，其中各基团和取代基的定义如说明书中所述。本发明还公开了所述化合物的制备方法及其作为KRAS G12C 抑制剂的用途。

USPTO Abstract

本发明涉及四氢吡啶并嘧啶类抑制剂及其制备方法和应用。具体地，本发明化合物具有式(I)所示结构，其中各基团和取代基的定义如说明书中所述。本发明还公开了所述化合物的制备方法及其作为KRAS G12C 抑制剂的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN112778301A
Jurisdiction
CN
Classification
—
Expires
2021-05-11
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Zejing Pharmaceutical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.